Audits and cohort studies on the adverse events of bee venom therapy

<p>AE: adverse event; SR: systemic reaction; LR: local reaction; LLR: large local reaction; VIT: venom immunotherapy; RVIT: rush VIT; SIT: specific immunotherapy; RSIT: rush-specific immunotherapy; CVIT; cluster VIT; IP: induction phase; EP: extension phase; MP: maintenance phase.</p><p>^a If it was not reported in prospective articles, it was considered a retrospective study.</p><p>^b Venom type: bees (family Apidae); wasps (family Vespidae); single (some bee venom or some wasp venom); mix (bee and wasp venom).</p><p>^c Incidence: number of patients with AEs/number of patients of total cases, %</p><p>^d Incidence: number of cases with AEs/number of patients of total cases.</p><p>^e Incidence: number of injections (dose) that resulted in AEs/total number of injections (dose), % (if the number of patients with AEs was not mentioned or precisely presented).</p><p>^f Incidence of AEs caused by BVTs combined with the incidence of AEs from other allergens.</p><p>^g This study was the only report of anaphylaxis related to BVT.</p><p>.